review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1005538361 |
P356 | DOI | 10.1007/S11926-002-0008-Y |
P698 | PubMed publication ID | 11890878 |
P2093 | author name string | Eugene Kissin | |
Joseph H Korn | |||
P2860 | cites work | Activated macrophages direct apoptosis and suppress mitosis of mesangial cells | Q73407093 |
Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast | Q73896690 | ||
Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro | Q73919594 | ||
Anti-Fas induces apoptosis and proliferation in human dermal fibroblasts: differences between foreskin and adult fibroblasts | Q74276848 | ||
Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung | Q77649804 | ||
Induction of apoptosis in rat hepatic stellate cells by disruption of integrin-mediated cell adhesion | Q77989647 | ||
Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids | Q78148901 | ||
Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors | Q28360101 | ||
Is liver fibrosis reversible? | Q33862568 | ||
TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target? | Q33913350 | ||
Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis | Q34159235 | ||
CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair | Q35764053 | ||
Type IV collagen and laminin regulate glomerular mesangial cell susceptibility to apoptosis via beta(1) integrin-mediated survival signals | Q35787750 | ||
Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation | Q35810015 | ||
Loss of matrix adhesion triggers rapid transformation-selective apoptosis in fibroblasts | Q36267653 | ||
Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts in vitro | Q38459769 | ||
Cytokines promote glomerular mesangial cell survival in vitro by stimulus-dependent inhibition of apoptosis | Q41086403 | ||
p53 modulation of anchorage independent growth and experimental metastasis. | Q41158020 | ||
Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts | Q42528899 | ||
The deletion of transforming growth factor-beta-induced myofibroblasts depends on growth conditions and actin organization | Q42795127 | ||
Differential production of apoptosis-modulating proteins in patients with hypertrophic burn scar | Q48007787 | ||
Induction of lung fibroblast apoptosis by soluble fibronectin peptides. | Q52541242 | ||
Cell cycle perturbations in normal and transformed fibroblasts caused by detachment from the substratum | Q53563220 | ||
Increased Expression of TGF-β Receptors by Scleroderma Fibroblasts: Evidence for Contribution of Autocrine TGF-β Signaling to Scleroderma Phenotype | Q60537838 | ||
TGFβ—a role in systemic sclerosis? | Q61646656 | ||
Expression of Fas antigen and Bcl-2 in human glomerulonephritis | Q70966218 | ||
Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts. Increased proportion of high collagen-producing cells in systemic sclerosis fibroblasts | Q71245367 | ||
Regulation of lung fibroblast alpha-smooth muscle actin expression, contractile phenotype, and apoptosis by IL-1beta | Q73026006 | ||
Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis | Q73092717 | ||
Inhibition of myofibroblast apoptosis by transforming growth factor beta(1) | Q73205575 | ||
Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides | Q73279064 | ||
Association of markers for TGFbeta3, TGFbeta2 and TIMP1 with systemic sclerosis | Q73342246 | ||
P433 | issue | 2 | |
P304 | page(s) | 129-135 | |
P577 | publication date | 2002-04-01 | |
P1433 | published in | Current Rheumatology Reports | Q23930052 |
P1476 | title | Apoptosis and myofibroblasts in the pathogenesis of systemic sclerosis | |
P478 | volume | 4 |
Q42474271 | Activation of key profibrotic mechanisms in transgenic fibroblasts expressing kinase-deficient type II Transforming growth factor-{beta} receptor (T{beta}RII{delta}k). |
Q42470563 | Attenuation of fibrosis with selective inhibition of c-Abl by siRNA in systemic sclerosis dermal fibroblasts. |
Q53884287 | Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts. |
Q48578569 | Exosomes isolated from serum of systemic sclerosis patients display alterations in their content of profibrotic and antifibrotic microRNA and induce a profibrotic phenotype in cultured normal dermal fibroblasts |
Q91718398 | Expression of apoptotic and proliferation factors in gastric mucosa of patients with systemic sclerosis correlates with form of the disease |
Q35180467 | Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma |
Q36135895 | Inhibition of MicroRNA-21 induces apoptosis in dermal fibroblasts of patients with systemic sclerosis |
Q35082007 | Mast cells in the pathogenesis of fibrosis |
Q52659036 | MicroRNA-29a induces apoptosis via increasing the Bax:Bcl-2 ratio in dermal fibroblasts of patients with systemic sclerosis. |
Q30355582 | Myocardial fibrosis in congenital and pediatric heart disease |
Q27692541 | Myofibroblasts: trust your heart and let fate decide. |
Q42557784 | Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions |
Q39953619 | Platelet-rich plasma (PRP) impairs the craniofacial bone repair associated with its elevated TGF-β levels and modulates the co-expression between collagen III and α-smooth muscle actin |
Q34146511 | Relaxin: antifibrotic properties and effects in models of disease |
Q34013195 | Serum amyloid P inhibits dermal wound healing |
Q37690207 | Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide |
Q35169051 | The vasculopathy of Raynaud's phenomenon and scleroderma |
Search more.